Amneal Pharmaceuticals

AMRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.022 B

$20.16 +7.75%

Close of 21 Sept 2026

Revenue

$3.02B

#917 by revenue

Earnings

$72.1M

#1432 by earnings

Shares outstanding

319,353,919

Latest filing cover page

P/E ratio

97.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#42Ionis PharmaceuticalsIONS$7.46B
#43AlkermesALKS$7.41B
#44Amneal PharmaceuticalsAMRX$7.02B
#45Belite BioBLTE$6.98B
#46Rhythm PharmaceuticalsRYTM$6.80B

What if Amneal Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$86,920.47

Per share 4,312× higher

Bitcoin $1.72T

$4,937.76

Per share 245× higher

Nvidia $5.48T

$15,733.34

Per share 780× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Amneal Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.